Contact Supplier

Contact Supplier

To get in touch with Biosynth, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    VIO Biosynth rebranded as Biosynth

    news-releasesBiosynth
    May 29th 2024

    Staad, Switzerland: – Complex chemical raw material specialist manufacturer and developer Biosynth AG marks the final phase of its incorporation of VIO Chemicals into the group with a brand migration exercise.

    The re-branding of VIO Biosynth to Biosynth took full effect on May 1, following the Zurich-based specialist chemical supplier’s acquisition by the Biosynth Group at the end of 2023. This means that the former VIO Biosynth will now be known as Biosynth AG for all purposes, including financial transactions and online identities.

    Strengthened capabilities

    The merger has strengthened the company by adding a Zurich office and increasing the reach of its leading chemical R&D expertise with connection to a global network of large-scale manufacturing partners.

    The branding change aligns the company’s operations with the rest of Biosynth and allows shared customers to access reliable, sustainable, and flexible manufacturing solutions at any production scale, further expanding Biosynth’s leading expertise across carbohydrates, nucleosides, intermediates, and specialty excipients, among others.

    As part of the name change, the VIO Biosynth customers will transact under Biosynth AG. Details of implications for partners and partners are detailed in a specially prepared FAQs page (see Resources).

    About Biosynth

    Biosynth is a supplier of critical raw materials, and services for diagnostics, vaccines and pharmaceuticals with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation.

    With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, Biosynth’s expertise and capability spans Complex Chemicals, Peptides, and Key Biologics, all from one trusted partner.  Headquartered in Staad, Switzerland, Biosynth is owned amongst others by KKR, Ampersand Capital Partners, and management.

    Find out more about Biosynth at www.Biosynth.com

    Resources

    Click on Rebrand of VIO Chemicals to Biosynth: FAQs for detailed information.
    Click on Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals for background information.

    VIO Biosynth rebranded as Biosynth

    Contact Biosynth

    Simply fill out the form below to contact Biosynth now.

    Send Biosynth a Message